Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.70
Ask:
2.00
Spread: 0.30 (17.647%)
Market Cap: £8.08m
RENX Live PriceLast checked at - London Stock Exchange

Intraday Renalytix Plc Share Chart

Director Dealing

19 Dec 2018 18:28

RNS Number : 0427L
Renalytix AI PLC
19 December 2018
 

 

Renalytix AI plc

 

("RenalytixAI" or the "Company") 

 

 

Director Dealing

 

 

The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 5,970 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 103 pence per share.

 

Following this purchase, Mr Mills is interested in 9,196,400 Ordinary Shares representing 17.09% of the total voting rights in the Company.

 

Enquiries:

 

Renalytix AI plc

www.renalytixai.com

James McCullough, CEO

Via Walbrook PR or

Tel: +1 646 397 3970

N+1 Singer (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell / James White / George Tzimas (Corporate Finance)

Tom Salvesen / Mia Gardner (Corporate Broking)

Walbrook PR Limited

Tel: 020 7933 8780

or renalytix@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

 

 

 

 

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Harwood Capital LLP (Harwood) as investment manager to NASCIT

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Christopher Mills, non-executive director of the issuer and director of North Altantic Smaller Companies Investment Trust plc (NASCIT)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Renalytix AI Plc

b)

 

LEI

 

 

213800NTOH3FK3WER551

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.25 pence each

 

Identification code

GB00BYWL4Y04

 

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

103 pence

5,970

 

 

 

 

 

d)

 

Aggregated information

N/A

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

19 December 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFKCDBFBDDQBD
Date   Source Headline
27th Jun 20251:09 pmRNSHolding(s) in Company
26th Jun 202511:48 amRNSHolding(s) in Company
17th Jun 20257:00 amRNSkidneyintelX.dkd data presented at ERA Congress
3rd Jun 20257:00 amRNSGrowing collaboration with NYKHM
30th May 202512:38 pmRNSHolding(s) in Company
29th May 202512:35 pmRNSHolding(s) in Company
27th May 202512:43 pmRNSHolding(s) in Company
20th May 20257:00 amRNSFirst use of KidneyIntelX in new CKD therapy trial
16th May 20253:10 pmRNSHolding(s) in Company
29th Apr 202511:03 amRNSHolding(s) in Company
22nd Apr 202512:47 pmRNSHolding(s) in Company
17th Apr 20252:56 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSHolding(s) in Company
16th Apr 20257:00 amRNSLate Breaking KidneyIntelX data show care impact
10th Apr 20257:00 amRNSQ3 Trading Update
9th Apr 20251:58 pmRNSHolding(s) in Company
7th Apr 202511:33 amRNSHolding(s) in Company
31st Mar 20251:21 pmRNSHolding(s) in Company
25th Mar 20252:59 pmRNSHolding(s) in Company
21st Mar 20251:34 pmRNSHolding(s) in Company
20th Mar 20254:19 pmRNSHolding(s) in Company
18th Mar 20257:00 amRNSHalf-year Report
12th Mar 202512:00 pmRNSNotice of Interim Results & Investor Presentation
12th Feb 20251:46 pmRNSHolding(s) in Company
11th Feb 202512:52 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNS-RPublication in journal (JASN) for kidneyIntelX.dkd
28th Jan 20251:26 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSTrading Update
17th Jan 20257:00 amRNSForeign Private Issuer re-qualification
30th Dec 20241:22 pmRNSGrant & Cancellation of Options
20th Dec 20244:27 pmRNSDirector/PDMR share purchase
19th Dec 202411:16 amRNSResult of AGM
19th Dec 20247:00 amRNSAGM Statement
17th Dec 20243:53 pmRNSHolding(s) in Company
11th Dec 202411:46 amRNSDirector/PDMR dealings
9th Dec 20245:27 pmRNSDirector/PDMR share purchase
6th Dec 20247:00 amRNSDirector/PDMR share purchase
4th Dec 202412:35 pmRNSDirector/PDMR share purchase
2nd Dec 20247:00 amRNSDirectorate Change
26th Nov 20242:06 pmRNSHolding(s) in Company
26th Nov 20247:00 amRNSPublication of Annual Report and Notice of AGM
25th Nov 20246:23 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSAudited Full Year Fiscal 2024 Results
20th Nov 20247:00 amRNSFinancial Results for Q1 of Fiscal Year 2025
8th Nov 20249:31 amRNSHolding(s) in Company
7th Nov 20244:35 pmRNSHolding(s) in Company
7th Nov 20241:20 pmRNSHolding(s) in Company
6th Nov 20242:25 pmRNSCancellation of Ordinary Shares & TVR
5th Nov 20247:00 amRNSDirectorate Change
5th Nov 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.